Terns Pharmaceuticals Inc (NASDAQ: TERN) kicked off on Monday, down -4.19% from the previous trading day, before settling in for the closing price of $5.01. Over the past 52 weeks, TERN has traded in a range of $4.32-$11.40.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
It was noted that within the last five years, the titan of the Healthcare sector saw sales slided by -25.00%. While this was happening, its average annual earnings per share was recorded 6.25%. With a float of $62.32 million, this company’s outstanding shares have now reached $84.92 million.
The extent of productivity of a business whose workforce counts for 66 workers is very important to gauge. In terms of profitability, gross margin is 47.35%, operating margin of -7562.78%, and the pretax margin is -6641.75%.
Terns Pharmaceuticals Inc (TERN) Insider and Institutional Ownership
Our next focus will be how large-scale investors are participating in this stock of the Biotechnology Industry. The insider ownership of Terns Pharmaceuticals Inc is 26.63%, while institutional ownership is 71.55%. The most recent insider transaction that took place on Jan 02 ’25, was worth 25,607. In this transaction Chief Medical Officer of this company sold 4,481 shares at a rate of $5.71, taking the stock ownership to the 54,269 shares. Before that another transaction happened on Jan 06 ’25, when Company’s Chief Financial Officer sold 9,059 for $5.80, making the entire transaction worth $52,500. This insider now owns 74,752 shares in total.
Terns Pharmaceuticals Inc (TERN) Latest Financial update
Wall Street market experts anticipate that the next fiscal year will bring earnings of -0.32 per share during the current fiscal year.
According to the Wall Street analysts, stocks earnings will be around 6.25% per share during the next fiscal year.
Terns Pharmaceuticals Inc (NASDAQ: TERN) Trading Performance Indicators
Take a look at Terns Pharmaceuticals Inc’s (TERN) current performance indicators. Last quarter, stock had a quick ratio of 32.99.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -1.18, a number that is poised to hit -0.30 in the next quarter and is forecasted to reach -1.32 in one year’s time.
Technical Analysis of Terns Pharmaceuticals Inc (TERN)
The latest stats from [Terns Pharmaceuticals Inc, TERN] show that its last 5-days average volume of 1.69 million was superior to 1.64 million than last year’s volume. As of the previous 9 days, the stock’s Stochastic %D was 8.78%. Additionally, its Average True Range was 0.39.
During the past 100 days, Terns Pharmaceuticals Inc’s (TERN) raw stochastic average was set at 2.37%, which indicates a significant decrease from 10.74% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 41.35% in the past 14 days, which was lower than the 77.29% volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $6.27, while its 200-day Moving Average is $6.96. Now, the first resistance to watch is $4.94. This is followed by the second major resistance level at $5.08. The third major resistance level sits at $5.23. If the price goes on to break the first support level at $4.65, it is likely to go to the next support level at $4.50. The third support level lies at $4.36 if the price breaches the second support level.
Terns Pharmaceuticals Inc (NASDAQ: TERN) Key Stats
The company with the Market Capitalisation of 407.70 million has total of 84,939K Shares Outstanding. Its annual sales at the moment are 0 K in contrast with the sum of -90,210 K annual income. Company’s last quarter sales were recorded 0 K and last quarter income was -21,950 K.
